SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-20-000278
Filing Date
2020-04-08
Accepted
2020-04-08 16:37:47
Documents
2
Period of Report
2020-04-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1616
2 POA attachment_1.htm EX-24 3692
  Complete submission text file 0001192482-20-000278.txt   6773
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5 GREAT VALLEY PARKWAY, SUITE 160 MALVERN PA 19355
Business Address
Castillo Kirsten (Reporting) CIK: 0001808806 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36751 | Film No.: 20782315